Cargando…
Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a s...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512147/ https://www.ncbi.nlm.nih.gov/pubmed/28748121 http://dx.doi.org/10.1016/j.jare.2017.04.006 |
_version_ | 1783250450094489600 |
---|---|
author | Ramirez, Maria Erika G. Bargman, Joanne M. |
author_facet | Ramirez, Maria Erika G. Bargman, Joanne M. |
author_sort | Ramirez, Maria Erika G. |
collection | PubMed |
description | Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a slowing in the rate of renal deterioration in those with chronic kidney disease. Given that there is little available in the general armamentarium to slow the rate of kidney deterioration, strong consideration could be given to the administration of agents or lifestyle changes that decrease uric acid production in hyperuricemic patients with deteriorating kidney function. |
format | Online Article Text |
id | pubmed-5512147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-55121472017-07-26 Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review Ramirez, Maria Erika G. Bargman, Joanne M. J Adv Res Review Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a slowing in the rate of renal deterioration in those with chronic kidney disease. Given that there is little available in the general armamentarium to slow the rate of kidney deterioration, strong consideration could be given to the administration of agents or lifestyle changes that decrease uric acid production in hyperuricemic patients with deteriorating kidney function. Elsevier 2017-09 2017-05-02 /pmc/articles/PMC5512147/ /pubmed/28748121 http://dx.doi.org/10.1016/j.jare.2017.04.006 Text en © 2017 Production and hosting by Elsevier B.V. on behalf of Cairo University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Ramirez, Maria Erika G. Bargman, Joanne M. Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review |
title | Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review |
title_full | Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review |
title_fullStr | Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review |
title_full_unstemmed | Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review |
title_short | Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review |
title_sort | treatment of asymptomatic hyperuricemia in chronic kidney disease: a new target in an old enemy – a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512147/ https://www.ncbi.nlm.nih.gov/pubmed/28748121 http://dx.doi.org/10.1016/j.jare.2017.04.006 |
work_keys_str_mv | AT ramirezmariaerikag treatmentofasymptomatichyperuricemiainchronickidneydiseaseanewtargetinanoldenemyareview AT bargmanjoannem treatmentofasymptomatichyperuricemiainchronickidneydiseaseanewtargetinanoldenemyareview |